CVRX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $1.55

Capitalizzazione di Mercato (MRQ) $41M

P/E (TTM) -0.8

EPS (TTM) $-1.97

Ricavi (TTM) $61M

ROE (TTM) -133.4%

D/E Debito/Patrimonio (MRQ) 2.9

Intervallo 52 sett. $2–$11

CVRX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su CVRx, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealth Care industriaHealth Care dipendenti223 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$57M

2020-12-31 → 2025-12-31

EPS$-2.04

2021-12-31 → 2025-12-31

Flusso di cassa libero$-41M

2021-12-31 → 2025-12-31

Margine netto-84.9%

2021-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	CVRX	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-0.8media 5 anni ≈-7.2	≈-7.2	·	·
P/S (TTM)	0.7media 5 anni ≈12.4	≈12.4	2.2	Valore equo
P/B (MRQ)	2.1media 5 anni ≈4.6	≈4.6	3.8	Sopravvalutato
EV / EBITDA	-0.3media 5 anni ≈-6.4	≈-6.4	·	·
Prezzo / FCF (TTM)	-1.0media 5 anni ≈-9.3	≈-9.3	·	·
Prezzo / Flusso di cassa (TTM)	-1.0media 5 anni ≈-9.5	≈-9.5	·	·
EV / Revenue (EV / Ricavi)	0.3media 5 anni ≈8.8	≈8.8	·	·
EV / FCF	-0.4media 5 anni ≈-7.1	≈-7.1	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	1.0media 5 anni ≈4.6	≈4.6	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	CVRX	media 5 anni	Mediana dei peer	Verdetto
Margine lordo (TTM)	86.9%media 5 anni ≈80.6%	≈80.6%	37.9%	Di prim'ordine
Margine Operativo (TTM)	-79.5%media 5 anni ≈-140.9%	≈-140.9%	-18.1%	Debole
EBITDA Margin (Margine EBITDA)	-90.5%media 5 anni ≈-140.9%	≈-140.9%	-17.5%	Debole
Margine ante imposte (TTM)	-84.9%media 5 anni ≈-165.8%	≈-165.8%	-11.6%	Debole
Margine di Profitto Netto (TTM)	-84.9%media 5 anni ≈-166.1%	≈-166.1%	-50.8%	Sotto la media
ROA (TTM)	-49.1%media 5 anni ≈-39.4%	≈-39.4%	-13.7%	Debole
ROE (TTM)	-133.4%media 5 anni ≈-62.9%	≈-62.9%	-81.1%	Debole
ROIC	-57.7%media 5 anni ≈-40.6%	≈-40.6%	-16.7%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	CVRX	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	2.9media 5 anni ≈0.5	≈0.5	1.8	Sopra la media
Rapporto corrente (MRQ)	8.0media 5 anni ≈14.9	≈14.9	2.7	Liquidità elevata
Quick Ratio	6.5media 5 anni ≈13.6	≈13.6	1.9	Liquidità elevata
Debito a lungo termine / Patrimonio netto (MRQ)	2.9media 5 anni ≈0.5	≈0.5	2.9	In linea

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	CVRX	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	10.4%media 5 anni ≈60.7%	≈60.7%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	36.1%media 5 anni ≈60.2%	≈60.2%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	56.4%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	CVRX	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-2.04media 5 anni ≈$-2.57	≈$-2.57	·	·
Revenue / Share (Ricavi / Azione)	$2.17media 5 anni ≈$1.86	≈$1.86	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-1.54media 5 anni ≈$-1.81	≈$-1.81	·	·
Cash / Share (Liquidità / Azione)	$2.88media 5 anni ≈$4.70	≈$4.70	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	CVRX	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.5media 5 anni ≈0.3	≈0.3	0.7	Debole
Inventory Turnover (Rotazione delle scorte)	0.7media 5 anni ≈0.8	≈0.8	2.3	Debole
Receivables Turnover (Rotazione dei crediti)	5.7media 5 anni ≈6.0	≈6.0	5.8	In linea
Revenue / Employee (Ricavi / Dipendente)	≈$254.0K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 1.1%

Prossimo report Nov 03, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 3, 2026	$-0.53	$-0.53	0.90%
31 Marzo 2026		$-0.50	$-0.51	2.8%
31 Dicembre 2025		$-0.46	$-0.45	-2.8%
30 Settembre 2025		$-0.49	$-0.51	4.2%
30 Giugno 2025		$-0.57	$-0.53	-7.5%
31 Marzo 2025		$-0.53	$-0.58	8.8%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 17

Metrica	2025	2024	2023	2022	2021	2020
Revenue	$57M	$51M	$39M	$22M	$13M	$6M
Cost of Revenue	$8M	$8M	$6M	$5M	$4M	$1M
Gross Profit	$48M	$43M	$33M	$17M	$9M	$5M
R&D Expense	$11M	$11M	$12M	$10M	$8M	$6M
SG&A Expense	$88M	$91M	$65M	$50M	$28M	$10M
Operating Expenses	$100M	$102M	$76M	$60M	$35M	$16M
Operating Income	$-51M	$-59M	$-43M	$-43M	$-26M	$-12M
Interest Expense	·	·	$2M	$165.0K	$2M	$2M
Other Non-op	$4M	$4M	$4M	$1M	$-15M	$-40.0K
Pretax Income	$-53M	$-60M	$-41M	$-41M	$-43M	$-14M
Income Tax	$-18.0K	$55.0K	$147.0K	$109.0K	$91.0K	$85.0K
Net Income	$-53M	$-60M	$-41M	$-41M	$-43M	$-14M
EPS (Basic)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·
EPS (Diluted)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·
Shares (Basic)	26,084,709	22,596,229	20,754,375	20,532,838	10,360,054	·
Shares (Diluted)	26,084,709	22,596,229	20,754,375	20,532,838	10,360,054	·
EBITDA	$-51M	$-59M	$-43M	$-43M	$-26M	·

Stato Patrimoniale 24

Metrica	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$76M	$106M	$91M	$106M	$142M	$59M
Receivables	$11M	$9M	$8M	$6M	$3M	$1M
Inventory	$12M	$12M	$11M	$7M	$4M	$3M
Prepaid Expense	$3M	$3M	$3M	$4M	$3M	$605.0K
Current Assets	$102M	$130M	$112M	$123M	$151M	$64M
PP&E (Net)	$2M	$3M	$2M	$2M	$1M	$410.0K
PP&E (Gross)	$6M	$6M	$5M	$4M	$3M	$2M
Accum. Depreciation	$4M	$3M	$3M	$2M	$2M	$2M
Other Non-current Assets	$26.0K	$27.0K	$27.0K	$27.0K	$26.0K	$26.0K
Total Assets	$105M	$133M	$115M	$125M	$153M	$65M
Accounts Payable	$4M	$3M	$2M	$2M	$510.0K	$483.0K
Accrued Liabilities	$9M	$8M	$6M	$6M	$5M	$4M
Current Liabilities	$13M	$11M	$8M	$8M	$6M	$8M
Capital Leases	$638.0K	$877.0K	$1M	$117.0K	$0	·
Other Non-current Liabilities	$2M	$1M	$1M	$805.0K	$681.0K	$777.0K
Total Liabilities	$65M	$62M	$39M	$16M	$7M	$28M
Long-term Debt	·	·	·	·	·	$19M
Total Debt	$50M	$49M	$29M	$7M	$0	·
Common Stock	$263.0K	$253.0K	$209.0K	$207.0K	$204.0K	$4.0K
Retained Earnings	$-591M	$-537M	$-477M	$-436M	$-395M	$-352M
AOCI	$-203.0K	$-206.0K	$-207.0K	$-207.0K	$-198.0K	$-190.0K
Stockholders' Equity	$39M	$71M	$76M	$109M	$146M	$-293M
Liabilities + Equity	$105M	$133M	$115M	$125M	$153M	$65M
Shares Outstanding	26,311,607	25,324,684	20,879,199	20,663,736	20,399,337	360,412

Flusso di cassa 11

Metrica	2025	2024	2023	2022	2021	2020
Stock-based Comp	$11M	$19M	$6M	$4M	$2M	$132.0K
Operating Cash Flow	$-40M	$-39M	$-39M	$-43M	$-28M	$-16M
CapEx	$580.0K	$1M	$591.0K	$685.0K	$1M	$311.0K
Investing Cash Flow	$-580.0K	$-1M	$-591.0K	$-685.0K	$-1M	$-311.0K
Net Debt Issued	·	·	·	$0	$-21M	·
Stock Issued	$9M	$33M	$0	$0	$133M	$0
Net Stock Activity	$9M	$33M	·	$0	$133M	·
Financing Cash Flow	$11M	$56M	$24M	$7M	$112M	$50M
Net Change in Cash	$-30M	$15M	$-16M	$-36M	$83M	$33M
Free Cash Flow	$-41M	$-41M	$-40M	$-43M	$-29M	·
Levered FCF	·	·	$-41M	$-44M	$-31M	·

Redditività 8

Metrica	2025	2024	2023	2022	2021	2020
Gross Margin	85.3%	83.8%	84.1%	77.8%	72.1%	·
Operating Margin	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%	·
Net Margin	-94.1%	-116.9%	-104.8%	-184.4%	-330.4%	·
Pretax Margin	-94.1%	-116.8%	-104.5%	-183.9%	-329.8%	·
EBITDA Margin	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%	·
ROA	-44.8%	-48.2%	-34.3%	-29.9%	-39.6%	·
ROE	-109.6%	-88.0%	-51.9%	-36.4%	-28.5%	·
ROIC	-57.7%	-49.5%	-41.1%	-36.8%	-17.8%	·

Liquidità e Solvibilità 5

Metrica	2025	2024	2023	2022	2021	2020
Current Ratio	7.6	12.1	14.3	15.2	25.6	·
Quick Ratio	6.5	10.7	12.5	13.8	24.5	·
Debt / Equity	1.3	0.7	0.4	0.1	0.0	·
LT Debt / Equity	1.3	0.7	0.4	0.1	0.0	·
Interest Coverage	·	·	-24.0	-257.7	-11.7	·

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020
Asset Turnover	0.5	0.4	0.3	0.2	0.1	·
Inventory Turnover	0.7	0.7	0.7	0.9	1.0	·
Receivables Turnover	5.7	6.1	6.0	5.6	6.8	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020
Book Value / Share	$1.49	$2.81	$3.64	$5.29	$7.16	·
Revenue / Share	$2.17	$2.27	$1.89	$1.09	·	·
Cash Flow / Share	$-1.54	$-1.73	$-1.88	$-2.08	·	·
Cash / Share	$2.88	$4.18	$4.34	$5.15	$6.96	·
EPS (TTM)	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020
Revenue YoY	10.4%	30.5%	74.9%	72.4%	115.4%	·
Revenue CAGR 3Y	36.1%	57.9%	86.6%	·	·	·
Revenue CAGR 5Y	56.4%	·	·	·	·	·

Valutazione (TTM) 14

Metrica	2025	2024	2023	2022	2021	2020
Revenue TTM	$57M	$51M	$39M	$22M	$13M	·
Net Income TTM	$-53M	$-60M	$-41M	$-41M	$-43M	·
Market Cap	$187M	$321M	$656M	$379M	$249M	·
Enterprise Value	$161M	$264M	$595M	$279M	$107M	·
P/E	-3.5	-4.8	-15.8	-9.1	-2.9	·
P/S	3.3	6.3	16.7	16.9	19.1	·
P/B	4.8	4.5	8.6	3.5	1.7	·
P / Tangible Book	4.8	4.5	8.6	3.5	1.7	·
P / Cash Flow	-4.7	-8.2	-16.8	-8.9	-9.0	·
P / FCF	-4.6	-7.9	-16.6	-8.7	-8.6	·
EV / EBITDA	-3.1	-4.4	-13.8	-6.6	-4.1	·
EV / FCF	-3.9	-6.5	-15.0	-6.4	-3.7	·
EV / Revenue	2.8	5.2	15.1	12.4	8.2	·
Earnings Yield	-28.7%	-20.9%	-6.3%	-11.0%	-34.0%	·

Conto Economico 17

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$16M	$15M	$16M	$15M	$14M	$12M	$15M	$13M	$12M	$11M	$11M	$11M	$10M	$8M	$7M	$6M
Cost of Revenue	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$2M	$1M
Gross Profit	$14M	$13M	$14M	$13M	$11M	$10M	$13M	$11M	$10M	$9M	$10M	$9M	$8M	$7M	$6M	$5M
R&D Expense	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$3M	$2M
SG&A Expense	$24M	$22M	$22M	$22M	$23M	$21M	$20M	$22M	$21M	$28M	$17M	$16M	$16M	$15M	$14M	$13M
Operating Expenses	$27M	$25M	$25M	$25M	$26M	$24M	$23M	$24M	$24M	$31M	$19M	$18M	$20M	$19M	$17M	$15M
Operating Income	$-13M	$-12M	$-11M	$-12M	$-14M	$-13M	$-10M	$-13M	$-14M	$-22M	$-10M	$-10M	$-12M	$-12M	$-11M	$-10M
Interest Expense	·	·	·	·	·	·	·	·	·	$960.0K	·	$499.0K	$481.0K	$240.0K	$165.0K	$0
Other Non-op	$560.0K	$593.0K	$660.0K	$875.0K	$1M	$1M	$1M	$917.0K	$944.0K	$1M	$1M	$1M	$616.0K	$1M	$1M	$328.0K
Pretax Income	$-14M	$-13M	$-12M	$-13M	$-15M	$-14M	$-11M	$-13M	$-14M	$-22M	$-9M	$-9M	$-12M	$-11M	$-11M	$-10M
Income Tax	$3.0K	$1.0K	$-7.0K	$-3.0K	$-3.0K	$-5.0K	$-71.0K	$47.0K	$41.0K	$38.0K	$39.0K	$40.0K	$34.0K	$34.0K	$28.0K	$32.0K
Net Income	$-14M	$-13M	$-12M	$-13M	$-15M	$-14M	$-11M	$-13M	$-14M	$-22M	$-9M	$-9M	$-12M	$-11M	$-11M	$-10M
EPS (Basic)	$-0.53	$-0.50	$-0.45	$-0.49	$-0.57	$-0.53	$-0.39	$-0.57	$-0.65	$-1.04	$-0.45	$-0.43	$-0.56	$-0.55	$-0.51	$-0.48
EPS (Diluted)	$-0.53	$-0.50	$-0.45	$-0.49	$-0.57	$-0.53	$-0.39	$-0.57	$-0.65	$-1.04	$-0.45	$-0.43	$-0.56	$-0.55	$-0.51	$-0.48
Shares (Basic)	26,515,442	26,355,591	·	26,168,562	26,071,316	25,876,062	·	22,783,337	21,628,542	21,232,009	·	20,801,350	20,711,850	20,693,224	·	20,576,838
Shares (Diluted)	26,515,442	26,355,591	·	26,168,562	26,071,316	25,876,062	·	22,783,337	21,628,542	21,232,009	·	20,801,350	20,711,850	20,693,224	·	20,576,838
EBITDA	$-13M	$-12M	·	$-12M	$-14M	$-13M	·	$-13M	$-14M	$-22M	·	$-10M	$-12M	$-12M	·	$-10M

Stato Patrimoniale 23

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$65M	$72M	$76M	$85M	$95M	$103M	$106M	$100M	$70M	$80M	$91M	$83M	$91M	$103M	$106M	$110M
Receivables	$9M	$9M	$11M	$8M	$7M	$9M	$9M	$9M	$9M	$8M	$8M	$6M	$7M	$6M	$6M	$5M
Inventory	$13M	$12M	$12M	$11M	$12M	$12M	$12M	$12M	$11M	$11M	$11M	$11M	$11M	$8M	$7M	$6M
Prepaid Expense	$2M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$4M	$3M	$4M	$3M
Current Assets	$89M	$97M	$102M	$108M	$116M	$126M	$130M	$124M	$92M	$102M	$112M	$104M	$112M	$121M	$123M	$124M
PP&E (Net)	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	$2M
PP&E (Gross)	$5M	$5M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$5M	$4M	$4M	$4M	$4M	$4M
Accum. Depreciation	$3M	$3M	$4M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$2M
Other Non-current Assets	$26.0K	$26.0K	$26.0K	$26.0K	$26.0K	$26.0K	$27.0K	$26.0K	$26.0K	$26.0K	$27.0K	$26.0K	$27.0K	$27.0K	$27.0K	$26.0K
Total Assets	$92M	$100M	$105M	$111M	$120M	$130M	$133M	$128M	$96M	$106M	$115M	$106M	$115M	$123M	$125M	$127M
Accounts Payable	$4M	$3M	$4M	$4M	$3M	$3M	$3M	$3M	$4M	$3M	$2M	$1M	$3M	$2M	$2M	$1M
Accrued Liabilities	$7M	$6M	$9M	$8M	$7M	$6M	$8M	$8M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M
Current Liabilities	$11M	$9M	$13M	$11M	$10M	$9M	$11M	$11M	$9M	$8M	$8M	$7M	$9M	$8M	$8M	$7M
Capital Leases	$448.0K	$544.0K	$638.0K	$730.0K	$819.0K	$802.0K	$877.0K	$951.0K	$1M	$1M	$1M	$916.0K	$946.0K	$59.0K	$117.0K	$175.0K
Other Non-current Liabilities	$2M	$2M	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$960.0K	$885.0K	$815.0K	$805.0K	$761.0K
Total Liabilities	$72M	$71M	$65M	$63M	$62M	$60M	$62M	$62M	$41M	$40M	$39M	$24M	$25M	$23M	$16M	$8M
Total Debt	$59M	$58M	·	$49M	$49M	$49M	·	$49M	$29M	$29M	·	$14M	$14M	$14M	·	·
Common Stock	$266.0K	$264.0K	$263.0K	$262.0K	$261.0K	$261.0K	$253.0K	$242.0K	$217.0K	$216.0K	$209.0K	$208.0K	$208.0K	$207.0K	$207.0K	$206.0K
Retained Earnings	$-618M	$-604M	$-591M	$-579M	$-566M	$-551M	$-537M	$-527M	$-514M	$-500M	$-477M	$-468M	$-459M	$-448M	$-436M	$-426M
AOCI	$-204.0K	$-203.0K	$-203.0K	$-204.0K	$-203.0K	$-205.0K	$-206.0K	$-208.0K	$-210.0K	$-210.0K	$-207.0K	$-208.0K	$-187.0K	$-204.0K	$-207.0K	$-219.0K
Stockholders' Equity	$20M	$29M	$39M	$48M	$58M	$69M	$71M	$65M	$55M	$66M	$76M	$83M	$90M	$100M	$109M	$118M
Liabilities + Equity	$92M	$100M	$105M	$111M	$120M	$130M	$133M	$128M	$96M	$106M	$115M	$106M	$115M	$123M	$125M	$127M
Shares Outstanding	26,641,597	26,428,767	26,311,607	26,193,733	26,145,951	26,051,992	25,324,684	24,203,658	21,712,357	21,593,173	20,879,199	20,813,612	20,750,910	20,708,940	20,663,736	20,578,963

Flusso di cassa 10

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$4M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$3M	$11M	$2M	$2M	$1M	$2M	$1M	$929.0K
Operating Cash Flow	$-9M	$-12M	$-10M	$-10M	$-8M	$-13M	$-8M	$-10M	$-10M	$-11M	$-8M	$-8M	$-13M	$-10M	$-11M	$-11M
CapEx	$112.0K	$122.0K	$68.0K	$295.0K	$103.0K	$114.0K	$52.0K	$37.0K	$355.0K	$917.0K	$169.0K	$39.0K	$143.0K	$240.0K	$79.0K	$264.0K
Investing Cash Flow	$-112.0K	$-122.0K	$-68.0K	$-295.0K	$-103.0K	$-114.0K	$-52.0K	$-37.0K	$-355.0K	$-917.0K	$-169.0K	$-39.0K	$-143.0K	$-240.0K	$-79.0K	$-264.0K
Stock Issued	$739.0K	$-43.0K	$-179.0K	$-45.0K	$0	$9M	$12M	$20M	$-1.0K	$547.0K	$0	$0	$0	$0	·	·
Net Stock Activity	·	$-43.0K	·	·	·	$9M	·	·	·	$547.0K	·	·	·	·	·	·
Financing Cash Flow	$1M	$9M	$410.0K	$103.0K	$392.0K	$10M	$14M	$40M	$472.0K	$1M	$16M	$363.0K	$473.0K	$8M	$7M	$7.0K
Net Change in Cash	$-8M	$-3M	$-9M	$-10M	$-8M	$-3M	$6M	$30M	$-10M	$-10M	$8M	$-8M	$-12M	$-3M	$-4M	$-11M
Free Cash Flow	·	$-12M	·	·	·	$-13M	·	·	·	$-12M	·	·	·	$-10M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-13M	·	·	·	$-11M	·	·

Redditività 8

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	87.4%	87.2%	·	86.8%	84.3%	83.5%	·	83.2%	83.9%	85.0%	·	83.9%	84.0%	83.4%	·	78.3%
Operating Margin	-82.9%	-82.3%	·	-83.5%	-105.8%	-108.8%	·	-97.3%	-118.3%	-206.4%	·	-90.6%	-123.7%	-152.4%	·	-163.7%
Net Margin	-89.4%	-88.8%	·	-87.6%	-108.4%	-111.5%	·	-98.0%	-118.8%	-206.0%	·	-85.7%	-122.6%	-142.6%	·	-158.9%
Pretax Margin	-89.4%	-88.8%	·	-87.6%	-108.5%	-111.5%	·	-97.6%	-118.5%	-205.7%	·	-85.4%	-122.3%	-142.1%	·	-158.4%
EBITDA Margin	-82.9%	-82.3%	·	-83.5%	-105.8%	-108.8%	·	-97.3%	-118.3%	-206.4%	·	-90.6%	-123.7%	-152.4%	·	-163.7%
ROA	-13.3%	-11.4%	·	-10.8%	-13.7%	-11.7%	·	-11.2%	-13.3%	-19.4%	·	-7.7%	-9.4%	-8.5%	·	-6.4%
ROE	-36.1%	-26.7%	·	-22.7%	-26.0%	-20.3%	·	-17.7%	-19.3%	-26.8%	·	-9.0%	-10.7%	-9.6%	·	-7.2%
ROIC	-16.6%	-13.9%	·	-12.6%	-13.4%	-11.3%	·	-11.4%	-16.6%	-23.3%	·	-9.8%	-11.3%	-10.7%	·	-8.6%

Liquidità e Solvibilità 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	8.0	10.2	·	9.6	12.0	14.8	·	11.3	10.1	12.2	·	14.0	12.6	15.2	·	16.8
Quick Ratio	6.7	8.6	·	8.3	10.5	13.1	·	10.0	8.7	10.6	·	12.1	10.9	13.8	·	15.6
Debt / Equity	2.9	2.0	·	1.0	0.9	0.7	·	0.8	0.5	0.4	·	0.2	0.2	0.1	·	·
LT Debt / Equity	2.9	2.0	·	1.0	0.9	0.7	·	0.8	0.5	0.4	·	0.2	0.2	0.1	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-23.2	·	-19.1	-24.4	-50.7	·	·

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.0
Inventory Turnover	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.3
Receivables Turnover	1.9	1.6	·	1.7	1.7	1.4	·	1.7	1.5	1.4	·	1.8	1.8	1.6	·	1.4

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.75	$1.10	·	$1.83	$2.22	$2.66	·	$2.69	$2.54	$3.07	·	$3.98	$4.34	$4.81	·	$5.75
Revenue / Share	$0.59	$0.56	·	$0.56	$0.52	$0.48	·	$0.59	$0.55	$0.51	·	$0.51	$0.46	$0.39	·	$0.30
Cash Flow / Share	·	$-0.46	·	·	·	$-0.49	·	·	·	$-0.51	·	·	·	$-0.50	·	·
Cash / Share	$2.42	$2.74	·	$3.25	$3.63	$3.94	·	$4.14	$3.24	$3.71	·	$3.99	$4.38	$4.99	·	$5.34
EPS (TTM)	$-1.97	$-2.01	·	$-1.98	$-2.06	$-2.14	·	$-2.71	$-2.57	$-2.48	·	$-2.05	$-2.10	$-2.08	·	$67.03

Valutazione (TTM) 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$61M	$59M	·	$56M	$55M	$53M	·	$47M	$44M	$42M	·	$35M	$31M	$26M	·	$19M
Net Income TTM	$-52M	$-53M	·	$-52M	$-52M	$-52M	·	$-58M	$-54M	$-52M	·	$-43M	$-43M	$-43M	·	$-41M
Market Cap	$137M	$250M	·	$211M	$154M	$319M	·	$213M	$260M	$393M	·	$316M	$320M	$193M	·	$192M
Enterprise Value	$131M	$236M	·	$176M	$108M	$265M	·	$162M	$219M	$342M	·	$247M	$244M	$104M	·	·
P/E	-2.6	-4.7	·	-4.1	-2.9	-5.7	·	-3.3	-4.7	-7.3	·	-7.4	-7.4	-4.5	·	0.1
P/S	2.2	4.2	·	3.8	2.8	6.0	·	4.5	5.9	9.3	·	9.0	10.4	7.3	·	10.1
P/B	6.9	8.6	·	4.4	2.7	4.6	·	3.3	4.7	5.9	·	3.8	3.6	1.9	·	1.6
P / Tangible Book	6.9	8.6	·	4.4	2.7	4.6	·	3.3	4.7	5.9	·	3.8	3.6	1.9	·	1.6
P / Cash Flow	·	-20.6	·	·	·	-25.0	·	·	·	-36.1	·	·	·	-18.8	·	·
EV / Revenue	2.1	4.0	·	3.1	2.0	5.0	·	3.4	4.9	8.1	·	7.0	7.9	3.9	·	·
Earnings Yield	-38.3%	-21.2%	·	-24.5%	-35.0%	-17.5%	·	-30.8%	-21.4%	-13.6%	·	-13.5%	-13.6%	-22.3%	·	718.4%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$57M	$51M	$39M	$22M	$13M
Margine Lordo %	85.3%	83.8%	84.1%	77.8%	72.1%
Margine Operativo %	-90.5%	-116.0%	-109.7%	-189.3%	-199.2%
Utile netto	$-53M	$-60M	$-41M	$-41M	$-43M
EPS Diluito	$-2.04	$-2.65	$-1.99	$-2.02	$-4.16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	1.3	0.7	0.4	0.1	0.0
Rapporto corrente	7.6	12.1	14.3	15.2	25.6
Quick Ratio	6.5	10.7	12.5	13.8	24.5

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-41M	$-41M	$-40M	$-43M	$-29M

Proprietari istituzionali (13F) 95 filer · $87.3M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 95

Valore detenuto $87.3M

Nuove posizioni 8

Posizioni chiuse 18

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
8 (-19 vs trimestre precedente)	18 (+5 vs trimestre precedente)	35 (+2 vs trimestre precedente)	29 (+9 vs trimestre precedente)	+574K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
JOHNSON & JOHNSON	$20.687.786	4.024.861	23,70%	Azioni
NEA Management Company, LLC	$10.045.822	1.954.440	11,51%	Azioni
VANGUARD GROUP INC	$7.956.707	1.120.663	9,12%	Azioni
BlackRock, Inc.	$6.401.661	1.245.459	7,33%	Azioni
ROYAL BANK OF CANADA	$6.338.000	1.233.212	7,26%	Azioni
GSK plc	$5.178.977	1.007.583	5,93%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$4.680.361	910.576	5,36%	Azioni
SILVERCREST ASSET MANAGEMENT GROUP LLC	$4.513.480	878.109	5,17%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$2.266.478	440.786	2,60%	Azioni
PFM Health Sciences, LP	$1.899.600	369.572	2,18%	Azioni
STATE STREET CORP	$1.883.049	366.352	2,16%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$1.182.200	230.000	1,35%	Azioni
UBS Group AG	$1.152.558	224.233	1,32%	Azioni
TUDOR INVESTMENT CORP ET AL	$1.057.216	205.684	1,21%	Azioni
GOLDMAN SACHS GROUP INC	$768.476	149.509	0,88%	Azioni
MORGAN STANLEY	$745.182	144.977	0,85%	Azioni
Kestra Advisory Services, LLC	$680.536	132.400	0,78%	Azioni
TWO SIGMA INVESTMENTS, LP	$680.526	132.398	0,78%	Azioni
VANGUARD FIDUCIARY TRUST CO	$662.829	128.955	0,76%	Azioni
DIMENSIONAL FUND ADVISORS LP	$659.866	127.971	0,76%	Azioni
NORTHERN TRUST CORP	$641.302	124.767	0,73%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$544.403	105.915	0,62%	Azioni
AQR CAPITAL MANAGEMENT LLC	$542.856	105.614	0,62%	Azioni
Cresset Asset Management, LLC	$533.784	103.849	0,61%	Azioni
AlphaQuest LLC	$502.645	70.795	0,58%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$500.168	97.309	0,57%	Azioni
Quantinno Capital Management LP	$423.192	82.333	0,48%	Azioni
CITADEL ADVISORS LLC	$406.127	79.013	0,47%	Azioni
Jump Financial, LLC	$398.350	77.500	0,46%	Azioni
Nuveen, LLC	$254.666	49.546	0,29%	Azioni
WOLVERINE TRADING, LLC	$228.312	29.346	0,26%	Azioni
ALLIANCEBERNSTEIN L.P.	$220.986	23.360	0,25%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$210.226	40.900	0,24%	Azioni
Bank of New York Mellon Corp	$198.641	38.646	0,23%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$181.946	35.398	0,21%	Azioni
Point72 Asset Management, L.P.	$137.613	26.773	0,16%	Azioni
XTX Topco Ltd	$112.181	21.825	0,13%	Azioni
JPMORGAN CHASE & CO	$109.932	18.507	0,13%	Azioni
Jain Global LLC	$109.482	21.300	0,13%	Azioni
Mitsubishi UFJ Asset Management Co., Ltd.	$106.532	20.726	0,12%	Azioni
RBF Capital, LLC	$102.800	20.000	0,12%	Azioni
BANK OF AMERICA CORP /DE/	$102.085	19.861	0,12%	Azioni
RHUMBLINE ADVISERS	$96.688	18.812	0,11%	Azioni
WELLS FARGO & COMPANY/MN	$85.797	16.692	0,10%	Azioni
Corton Capital Inc.	$85.461	10.590	0,10%	Azioni
MILLENNIUM MANAGEMENT LLC	$84.476	16.435	0,10%	Azioni
Graham Capital Management, L.P.	$76.884	14.958	0,09%	Azioni
CWM, LLC	$76.238	8.059	0,09%	Azioni
JANE STREET GROUP, LLC	$69.390	13.500	0,08%	Opzione Call
R Squared Ltd	$68.907	13.406	0,08%	Azioni

Mostra tutti i 95 proprietari istituzionali →

Attivisti e proprietari del 5%+ 4 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Chernett Jorey ×2 depositi	02 Ottobre 2026	0,62%	Modifica	·	SEC
New Enterprise Associates 10, Limited Partnership, New Enterprise Associates 8A, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell	20 Febbraio 2025	7,80%	Modifica	·	SEC
Cooperatieve Gilde Healthcare IV U.A., Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., Martemanshurk B.V. ×4 depositi	06 Febbraio 2025	4,90%	Modifica	·	SEC
New Enterprise Associates 8A, Limited Partnership, New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 depositi	07 Novembre 2024	·	Deposito iniziale	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 25 insider · 11 dirigenti · 9 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
Kevin Hykes	PRES & CEO	27 Febbraio 2026 A	284.237	0	1	$-61.328
Nadim Yared	CHIEF EXECUTIVE OFFICER	02 Febbraio 2024 A	26.255	0	0	$0
Jared Oasheim	CHIEF FINANCIAL OFFICER	27 Febbraio 2026 A	96.703	0	1	$-13.778
Brent Binkowski	CHIEF OPERATING OFFICER	13 Agosto 2026 P	56.514	1	1	$72.971
Philip B. Adamson	Chief Medical Officer	27 Febbraio 2026 A	61.578	0	1	$-9.970
Robert Allen John	Chief Revenue Officer	27 Febbraio 2026 A	86.036	0	1	$-31.316
Paul Verrastro	CHIEF MKTG & STRAT OFFICER	27 Febbraio 2026 A	60.551	0	1	$-10.144
Craig E. Palmer	SVP, U.S. SALES	25 Marzo 2024 M	1.229	0	0	$0
Liz Galle	VP OF GLOBAL CLINICAL RESEARCH	16 Ottobre 2023 M	778	0	0	$0
Dean Bruhn-Ding	VP OF REG. AFFAIRS AND QA	02 Agosto 2022 A	54.648	0	0	$0
John Brintnall	CHIEF STRATEGY OFFICER AND SEC	22 Aprile 2022 M	21.901	0	0	$0
Martha Shadan	Direttore	01 Giugno 2026 A	8.720	0	0	$0
Mitch C. Hill,	Direttore	01 Giugno 2026 A	8.720	0	0	$0
Mudit K. Jain	Direttore	01 Giugno 2026 A	14.370	2	0	$300.432
Kevin J. Ballinger	Direttore	01 Giugno 2026 A	8.720	0	0	$0
Kirk Nielsen	Direttore	01 Giugno 2026 A	8.720	0	0	$0
Ali Behbahani	Direttore	04 Giugno 2024 A	316	0	0	$0
John M Nehra	Direttore	07 Giugno 2022 A	28.266	0	0	$0
Johnson & Johnson Innovation - JJDC, Inc.	Proprietario del 10%	15 Settembre 2023 J	0	0	0	$0
New Enterprise Associates 10, Limited Partnership	Proprietario del 10%	02 Luglio 2021 C	2.026.083	0	0	$0
Joseph P Slattery	·	01 Giugno 2026 A	39.365	0	0	$0
DALE MICHAEL D	·	01 Giugno 2026 A	29.005	0	0	$0
Gregory Morrison	·	02 Marzo 2026 A	34.000	0	0	$0
Geoffrey B Pardo	·	02 Luglio 2021 C	1.829.022	0	0	$0
GSK plc	·	02 Luglio 2021 C	1.007.583	0	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 14 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IWC · iShares Trust	0,01%	51.258 SH	11 Settembre 2026	Giornaliero
IWO · iShares Trust	0,00%	156.004 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,00%	7.352 NS	31 Luglio 2026	N-PORT
IWM · iShares Trust	0,00%	364.840 SH	11 Settembre 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,00%	28.363 NS	31 Luglio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	1.354 NS	31 Luglio 2026	N-PORT
IWV · iShares Trust	0,00%	5.299 SH	03 Settembre 2026	Giornaliero
DFAC · Dimensional ETF Trust	0,00%	5.367 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	204.533 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	684.121 SH	19 Agosto 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,00%	89.003 SH	19 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,00%	15.722 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	1.190 SH	19 Agosto 2026	Giornaliero
DXUV · Dimensional ETF Trust	0,00%	4 NS	31 Luglio 2026	N-PORT

CVRX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 13 analisti COMPRA

Target mediano $4.50 +190,3%

3 23,1% Acquisto forte

6 46,2% Compra

3 23,1% Mantieni

1 7,7% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

6 analisti · 2026-10-03

Target medio $4.58 +195,7%

← Sotto tutti i target Prezzo attuale $1.55

Basso$3.50 Media$4.58 Alto$6.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
CVRX	$187M	-3.5	10.4%	-94.1%	-109.6%	85.3%
MDAI	·	·	·	·	·	·
ODYS	$54M	-3.1	-23.9%	-565.0%	-58.7%	28.9%
SRTS	$66M	-8.5	-34.3%	-28.1%	-15.4%	43.2%
POCI	$56M	-11.9	65.2%	-11.5%	-24.5%	17.2%
SNWV	$256M	72.8	35.0%	26.8%	-395.5%	77.1%
QTI	$73M	-3.0	287.9%	-111.4%	-688.9%	45.4%
ARAY	$31M	-0.9	-12.3%	-12.2%	-103.4%	27.7%

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

CVRX CVRx, Inc. - Common Stock

CVRX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

CVRX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Informazioni su CVRx, Inc. - Common Stock Panoramica della società da Wikipedia

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Proprietari istituzionali (13F) 95 filer · $87.3M totale · Aggiornato al 30 Giugno 2026

Attivisti e proprietari del 5%+ 4 partecipazioni

Insider aziendali 25 insider · 11 dirigenti · 9 direttori

Proprietà ETF Posseduti da 14 ETF

CVRX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi